Recent Finacing
Recent Raise
Hinge Bio is a development-stage biotech that uses its GEM-DIMER platform to design multivalent, multispecific antibody therapeutics and is advancing HB2198 into Phase 1 for lupus.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Hinge Bio.
